» Articles » PMID: 38468200

The Effect of in Vitro Simulated Colonic PH Gradients on Microbial Activity and Metabolite Production Using Common Prebiotics As Substrates

Overview
Journal BMC Microbiol
Publisher Biomed Central
Specialty Microbiology
Date 2024 Mar 12
PMID 38468200
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The interplay between gut microbiota (GM) and the metabolization of dietary components leading to the production of short-chain fatty acids (SCFAs) is affected by a range of factors including colonic pH and carbohydrate source. However, there is still only limited knowledge on how the GM activity and metabolite production in the gastrointestinal tract could be influenced by pH and the pH gradient increases along the colon.

Results: Here we investigate the effect of pH gradients corresponding to levels typically found in the colon on GM composition and metabolite production using substrates inulin, lactose, galactooligosaccharides (GOS), and fructooligosaccharide (FOS) in an in vitro colon setup. We investigated 3 different pH regimes (low, 5.2 increasing to 6.4; medium, 5.6 increasing to 6.8 and high, 6.0 increasing to 7.2) for each fecal inoculum and found that colonic pH gradients significantly influenced in vitro simulated GM structure, but the influence of fecal donor and substrate was more pronounced. Low pH regimes strongly influenced GM with the decreased relative abundance of Bacteroides spp. and increased Bifidobacterium spp. Higher in vitro simulated colonic pH promoted the production of SCFAs in a donor- and substrate-dependent manner. The butyrate producer Butyricimonas was enriched at higher pH conditions, where also butyrate production was increased for inulin. The relative abundance of Phascolarctobacterium, Bacteroides, and Rikenellaceae also increased at higher colonic pH, which was accompanied by increased production of propionate with GOS and FOS as substrates.

Conclusions: Together, our results show that colonic substrates such as dietary fibres influence GM composition and metabolite production, not only by being selectively utilized by specific microbes, but also because of their SCFA production, which in turn also influences colonic pH and overall GM composition and activity. Our work provides details about the effect of the gradients of rising pH from the proximal to distal colon on fermenting dietary substrates in vitro and highlights the importance of considering pH in GM research.

Citing Articles

Exploring Gut Microbiota Imbalance in Irritable Bowel Syndrome: Potential Therapeutic Effects of Probiotics and Their Metabolites.

Garcia Mansilla M, Rodriguez Sojo M, Lista A, Ayala Mosqueda C, Ruiz Malagon A, Galvez J Nutrients. 2025; 17(1.

PMID: 39796588 PMC: 11723002. DOI: 10.3390/nu17010155.


The Significance of Plant Nutrition in the Creation of the Intestinal Microbiota-Prevention of Chronic Diseases: A Narrative Review.

Jovandaric M, Jovanovic K, Raus M, Babic S, Igic T, Kotlica B Medicina (Kaunas). 2025; 60(12.

PMID: 39768848 PMC: 11678629. DOI: 10.3390/medicina60121969.


Probiotics and Prebiotics Intervention in Respiratory and Digestive Infections Linked to Covid-19.

Amrouche T, Lammi S, Drider D Probiotics Antimicrob Proteins. 2024; .

PMID: 39614066 DOI: 10.1007/s12602-024-10404-2.

References
1.
Shalon D, Culver R, Grembi J, Folz J, Treit P, Shi H . Profiling the human intestinal environment under physiological conditions. Nature. 2023; 617(7961):581-591. PMC: 10191855. DOI: 10.1038/s41586-023-05989-7. View

2.
Ilhan Z, Marcus A, Kang D, Rittmann B, Krajmalnik-Brown R . pH-Mediated Microbial and Metabolic Interactions in Fecal Enrichment Cultures. mSphere. 2017; 2(3). PMC: 5415631. DOI: 10.1128/mSphere.00047-17. View

3.
Sanders M, Merenstein D, Reid G, Gibson G, Rastall R . Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. 2019; 16(10):605-616. DOI: 10.1038/s41575-019-0173-3. View

4.
Monteagudo-Mera A, Arthur J, Jobin C, Keku T, Bruno-Barcena J, Azcarate-Peril M . High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. Benef Microbes. 2016; 7(2):247-64. PMC: 4974821. DOI: 10.3920/BM2015.0114. View

5.
Payne A, Zihler A, Chassard C, Lacroix C . Advances and perspectives in in vitro human gut fermentation modeling. Trends Biotechnol. 2011; 30(1):17-25. DOI: 10.1016/j.tibtech.2011.06.011. View